p21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage

Cell Cycle

Volumn 8, Issue 2, 2009, Pages 253-256

  Gillis, Laura D ^a   Leidal, Andrew M ^a   Hill, Richard ^a   Lee, Patrick W K ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cell cycle; Cyclin B1; DNA damage response; p21; p53

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; ETOPOSIDE; PROTEIN P21; CDKN1A PROTEIN, HUMAN; CYCLIN B; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN P53;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DNA CONTENT; DNA DAMAGE; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WILD TYPE; FLOW CYTOMETRY; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; FLOW CYTOMETRY; G2 PHASE; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 58549085408     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.2.7550     Document Type: Article

References (21)

1. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25.
2. 1 cyclin-dependent kinases. Cell 1993; 75:805-16.
3. 2 phase after DNA damage in normal human fibroblasts. EMBO J 2003; 22:3992-4002.
4. 2 arrest after DNA damage. Science 1998; 282:1497-501.
5. Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev 2000; 14:1584-8.
6. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996; 381:713-6.
7. Morgan DO. Principles of CDK regulation. Nature 1995; 374:131-4.
8. Hagting A, Karlsson C, Clute P, Jackman M, Pines J. MPF localization is controlled by nuclear export. EMBO J 1998; 17:4127-38.
9. 2/M transition. Cancer Surv 1997; 29:47-73.
10. Pines J. Cyclins: wheels within wheels. Cell Growth Differ 1991; 2:305-10.
11. Reed SI. Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat Rev Mol Cell Biol 2003; 4:855-64.
12. Sudakin V, Ganoth D, Dahan A, Heller H, Hershko J, Luca FC, et al. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell 1995; 6:185-97.
13. 2 checkpoint through cyclin B1. Proc Natl Acad Sci USA 1999; 96:2147-52.
14. Innocente SA, Lee JM. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription. FEBS Lett 2005; 579:1001-7.
15. Yin XY, Grove L, Datta NS, Katula K, Long MW, Prochownik EV. Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression. Cancer Res 2001; 61:6487-93.
16. Broude EV, Swift ME, Vivo C, Chang BD, Davis BM, Kalurupalle S, et al. p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation. Oncogene 2007; 26:6954-8.
17. Charrier-Savournin FB, Chateau MT, Gire V, Sedivy J, Piette J, Dulic V. p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol Biol Cell 2004; 15:3965-76.
18. 2 checkpoint in vertebrate cells. EMBO J 2001; 20:6499-508.
19. Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, Sedivy J, et al. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 2002; 277:17154-60.
20. Soussi T, Ishioka C, Claustres M, Beroud C. Locus-specific mutation databases: pitfalls and good practice based on the p53 experience. Nat Rev Cancer 2006; 6:83-90.
21. Gartel AL. Is p21 an oncogene? Mol Cancer Ther 2006; 5:1385-6.